Vitanza NA, Monje M (2019) Diffuse intrinsic pontine glioma: from diagnosis to next-generation clinical trials. Curr Treat Options Neurol 21:1–11. https://doi.org/10.1007/S11940-019-0577-Y/FIGURES/1
van Zanten SEMV, Jansen MH, Sanchez Aliaga E, van Vuurden DG, Vandertop WP, Kaspers GJ (2015) A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands. Expert Rev Anticancer Ther 15:157–164. https://doi.org/10.1586/14737140.2015.974563
Chen J, Lin Z, Barrett L, Dai L, Qin Z (2020) Identification of New Therapeutic Targets and Natural Compounds against Diffuse Intrinsic Pontine Glioma (DIPG). Bioorg Chem 99:103847. https://doi.org/10.1016/J.BIOORG.2020.103847
Article CAS PubMed PubMed Central Google Scholar
Gwak HS, Park HJ (2017) Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG). Crit Rev Oncol Hematol 120:111–119. https://doi.org/10.1016/J.CRITREVONC.2017.10.013
Johung TB, Monje M (2017) diffuse intrinsic pontine glioma: new pathophysiological insights and emerging therapeutic targets. Curr Neuropharmacol 15:88. https://doi.org/10.2174/1570159X14666160509123229
Article CAS PubMed PubMed Central Google Scholar
Castel D, Philippe C, Calmon R, le Dret L, Truffaux N, Boddaert N, Pagès M, Taylor KR, Saulnier P, Lacroix L, Mackay A, Jones C, Sainte-Rose C, Blauwblomme T, Andreiuolo F, Puget S, Grill J, Varlet P, Debily MA (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815. https://doi.org/10.1007/S00401-015-1478-0
Article CAS PubMed PubMed Central Google Scholar
Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Zhang J, Baker SJ (2012) Somatic histone H3 alterations in paediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44:251. https://doi.org/10.1038/NG.1102
Article CAS PubMed PubMed Central Google Scholar
Hyland EM, Cosgrove MS, Molina H, Wang D, Pandey A, Cottee RJ, Boeke JD (2005) Insights into the role of histone H3 and histone H4 Core modifiable residues in saccharomyces cerevisiae. Mol Cell Biol 25:10060. https://doi.org/10.1128/MCB.25.22.10060-10070.2005
Article CAS PubMed PubMed Central Google Scholar
Kfoury-Beaumont N, Prakasam R, Pondugula S, Lagas JS, Matkovich S, Gontarz P, Yang L, Yano H, Kim AH, Rubin JB, Kroll KL (2022) The H3K27M mutation alters stem cell growth, epigenetic regulation, and differentiation potential. BMC Biol 20:1–20. https://doi.org/10.1186/S12915-022-01324-0/FIGURES/7
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/NEUONC/NOAB106
Article CAS PubMed PubMed Central Google Scholar
Pellot JE, de Jesus O (2022) Diffuse Intrinsic Pontine Glioma. StatPearls, St. Petersburg
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD (1993) Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group. Neurosurgery 33:1026–1030. https://doi.org/10.1227/00006123-199312000-00010
Article CAS PubMed Google Scholar
Williams JR, Young CC, Vitanza NA, Mcgrath M, Feroze AH, Browd SR, Hauptman JS (2020) Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care. Neurosurg Focus. https://doi.org/10.3171/2019.9.FOCUS19745
Gupta N, Goumnerova LC, Manley P, Chi SN, Neuberg D, Puligandla M, Fangusaro J, Goldman S, Tomita T, Alden T, Dipatri A, Rubin JB, Gauvain K, Limbrick D, Leonard J, Geyer JR, Leary S, Browd S, Wang Z, Sood S, Bendel A, Nagib M, Gardner S, Karajannis MA, Harter D, Ayyanar K, Gump W, Bowers DC, Weprin B, Macdonald TJ, Aguilera D, Brahma B, Robison NJ, Kiehna E, Krieger M, Sandler E, Aldana P, Khatib Z, Ragheb J, Bhatia S, Mueller S, Banerjee A, Bredlau AL, Gururangan S, Fuchs H, Cohen KJ, Jallo G, Dorris K, Handler M, Comito M, Dias M, Nazemi K, Baird L, Murray J, Lindeman N, Hornick JL, Malkin H, Sinai C, Greenspan L, Wright KD, Prados M, Bandopadhayay P, Ligon KL, Kieran MW (2018) Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma. Neuro Oncol 20:1547. https://doi.org/10.1093/NEUONC/NOY070
Article CAS PubMed PubMed Central Google Scholar
Clymer J, Kieran MW (2018) The integration of biology into the treatment of diffuse intrinsic pontine glioma: a review of the North American clinical trial perspective. Front Oncol 8:169. https://doi.org/10.3389/FONC.2018.00169
Article PubMed PubMed Central Google Scholar
Schroeder KM, Hoeman CM (2014) Becher OJ (2013) Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology. Pediatr Res 75(1):205–209. https://doi.org/10.1038/pr.2013.194
Article CAS PubMed Google Scholar
Puget S, Beccaria K, Blauwblomme T, Roujeau T, James S, Grill J, Zerah M, Varlet P, Sainte-Rose C (2015) Biopsy in a series of 130 pediatric diffuse intrinsic pontine gliomas. Child’s Nerv Syst 31:1773–1780. https://doi.org/10.1007/S00381-015-2832-1/FIGURES/3
Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP (1986) Diagnosis and management of pediatric brain-stem gliomas. J Neurosurg 65:745–750. https://doi.org/10.3171/JNS.1986.65.6.0745
Article CAS PubMed Google Scholar
Pfaff E, el Damaty A, Balasubramanian GP, Blattner-Johnson M, Worst BC, Stark S, Witt H, Pajtler KW, van Tilburg CM, Witt R, Milde T, Jakobs M, Fiesel P, Frühwald MC, Hernáiz Driever P, Thomale UW, Schuhmann MU, Metzler M, Bochennek K, Simon T, Dürken M, Karremann M, Knirsch S, Ebinger M, von Bueren AO, Pietsch T, Herold-Mende C, Reuss DE, Kiening K, Lichter P, Eggert A, Kramm CM, Pfister SM, Jones DTW, Bächli H, Witt O (2019) Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience. Eur J Cancer 114:27–35. https://doi.org/10.1016/J.EJCA.2019.03.019
Buczkowicz P, Hawkins C (2015) Pathology, molecular genetics, and epigenetics of diffuse intrinsic pontine glioma. Front Oncol 5:147. https://doi.org/10.3389/FONC.2015.00147/BIBTEX
Article PubMed PubMed Central Google Scholar
Kickingereder P, Willeit P, Simon T, Ruge MI (2013) Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 72:873–881. https://doi.org/10.1227/NEU.0B013E31828BF445
Hamisch C, Kickingereder P, Fischer M, Simon T, Ruge MI (2017) Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases. J Neurosurg Pediatr 20:261–268. https://doi.org/10.3171/2017.2.PEDS1665
Dellaretti M, Reyns N, Touzet G, Dubois F, Gusmão S, Pereira JLB, Blond S (2012) Stereotactic biopsy for brainstem tumors: comparison of transcerebellar with transfrontal approach. Stereotact Funct Neurosurg 90:79–83. https://doi.org/10.1159/000335502
Carai A, Mastronuzzi A, de Benedictis A, Messina R, Cacchione A, Miele E, Randi F, Esposito G, Trezza A, Colafati GS, Savioli A, Locatelli F, Marras CE (2017) Robot-assisted stereotactic biopsy of diffuse intrinsic pontine glioma: a single-center experience. World Neurosurg 101:584–588. https://doi.org/10.1016/J.WNEU.2017.02.088
Dhawan S, He Y, Bartek J, Alattar AA, Chen CC (2019) Comparison of frame-based versus frameless intracranial stereotactic biopsy: systematic review and meta-analysis. World Neurosurg 127:607-616.e4. https://doi.org/10.1016/J.WNEU.2019.04.016
Jaradat A, Nowacki A, Fichtner J, Schlaeppi JA, Pollo C (2021) Stereotactic biopsies of brainstem lesions: which approach? Acta Neurochir (Wien) 163:1957–1964. https://doi.org/10.1007/S00701-021-04733-2/FIGURES/6
Mosaab A, El-Ayadi M, Khorshed EN, Amer N, Refaat A, El-Beltagy M, Hassan Z, Soror SH, Zaghloul MS (2020) El-Naggar S (2020) histone H3K27M mutation overrides histological grading in pediatric gliomas. Sci Rep 10(1):1–9. https://doi.org/10.1038/s41598-020-65272-x
Dang H, Khan AB, Gadgil N, Prablek M, Lin FY, Blessing MM, Aldave G, Bauer D (2023) Primary spinal intramedullary anaplastic ganglioglioma in a pediatric patient. Surg Neurol Int 14:55. https://doi.org/10.25259/SNI_825_2022
Article PubMed PubMed Central Google Scholar
Orillac C, Thomas C, Dastagirzada Y, Hidalgo ET, Golfinos JG, Zagzag D, Wisoff JH, Karajannis MA, Snuderl M (2016) Pilocytic astrocytoma and glioneuronal tumor with histone H3 K27M mutation. Acta Neuropathol Commun 4:84–84. https://doi.org/10.1186/S40478-016-0361-0
Article PubMed PubMed Central Google Scholar
Jovanovich N, Habib A, Head J, Hameed F, Agnihotri S, Zinn PO (2023) Pediatric diffuse midline glioma: understanding the mechanisms and assessing the next generation of personalized therapeutics. Neurooncol Adv 5:1–12. https://doi.org/10.1093/NOAJNL/VDAD040
Hoeman C, Shen C, Becher OJ (2018) CDK4/6 and PDGFRA signaling as therapeutic targets in diffuse intrinsic pontine glioma. Front Oncol. https://doi.org/10.3389/FONC.2018.00191
Article PubMed PubMed Central Google Scholar
Werbrouck C, Evangelista CCS, Lobón-Iglesias MJ, Barret E, Le Teuff G, Merlevede J, Brusini R, Kergrohen T, Mondini M, Bolle S, Varlet P, Beccaria K, Boddaert N, Puget S, Grill J, Debily MA, Castel D (2019) TP53 pathway alterations drive radioresistance in diffuse intrinsic pontine gliomas (DIPG). Clin Cancer Res 25:6788–6800. https://doi.org/10.1158/1078-0432.CCR-19-0126
Comments (0)